Literature DB >> 21852356

Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord.

Frank W Floeth1, Gabriele Stoffels, Jörg Herdmann, Sven Eicker, Norbert Galldiks, Sascha Rhee, Hans-Jakob Steiger, Karl-Josef Langen.   

Abstract

UNLABELLED: MRI offers perfect visualization of spondylotic stenosis of the cervical spine, but morphologic imaging does not correlate with clinical symptoms and postoperative recovery after decompression surgery. In this prospective study, we investigated the role of (18)F-FDG PET in patients with degenerative stenosis of the cervical spinal cord in relation to postsurgical outcome.
METHODS: Twenty patients with monosegmental spondylotic stenosis of the middle cervical spine (C3/C4 or C4/C5) showing intramedullary hyperintensity on T2-weighted MRI and clinical symptoms of myelopathy (myelopathic patients) were investigated by (18)F-FDG PET. Maximum standardized uptake values (SUV(max)) were measured at all levels of the cervical spine (C1-C7). Decompression surgery and anterior cervical fusion were performed on all patients, and clinical status (Japanese Orthopedic Association [JOA] score) was assessed before and 6 mo after surgery. The (18)F-FDG data of 10 individuals without cervical spine pathology were used as a reference (controls).
RESULTS: The myelopathic patients showed a significant decrease in (18)F-FDG uptake in the area of the lower cervical cord, compared with the control group (C7 SUV(max), 1.49 ± 0.18 vs. 1.71 ± 0.27, P = 0.01). Ten myelopathic patients exhibited focally increased (18)F-FDG uptake at the level of the stenosis (SUV(max), 2.27 ± 0.41 vs. 1.75 ± 0.22, P = 0.002). The remaining 10 patients showed inconspicuous (18)F-FDG uptake at the area of the stenosis. Postoperatively, the patients with focally increased (18)F-FDG accumulation at the level of stenosis showed good clinical recovery and a significant improvement in JOA scores (13.6 ± 2.3 vs. 9.5 ± 2.5, P = 0.001), whereas no significant improvement was observed in the remaining patients (JOA score, 12.0 ± 2.4 vs. 11.6 ± 2.5, not statistically significant). Multiple regression analysis identified the presence of focally increased (18)F-FDG uptake at the level of the stenosis as an independent predictor of postoperative outcome (P = 0.002).
CONCLUSION: The results suggest that regional changes in (18)F-FDG uptake have prognostic significance in compression-induced cervical myelopathy that may be helpful in decisions on the timing of surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852356     DOI: 10.2967/jnumed.111.091801

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Physiological ¹⁸F-FDG uptake by the spinal cord: is it a point of consideration for cancer patients?

Authors:  Amr Amin; Sandra J Rosenbaum; Andreas Bockisch
Journal:  J Neurooncol       Date:  2012-01-17       Impact factor: 4.130

2.  Diffusion-weighted magnetic resonance imaging for the diagnosis of patients with lumbar nerve root entrapment syndromes: results from a pilot study.

Authors:  Maximilian Reinhold; Christian Ederer; Benjamin Henninger; Alexandra Eberwein; Christian Kremser
Journal:  Eur Spine J       Date:  2014-10-09       Impact factor: 3.134

3.  SV2A PET Imaging Is a Noninvasive Marker for the Detection of Spinal Damage in Experimental Models of Spinal Cord Injury.

Authors:  Daniele Bertoglio; Nicolas Halloin; Stef De Lombaerde; Aleksandar Jankovski; Jeroen Verhaeghe; Charles Nicaise; Steven Staelens
Journal:  J Nucl Med       Date:  2022-01-13       Impact factor: 11.082

Review 4.  The current state-of-the-art of spinal cord imaging: methods.

Authors:  P W Stroman; C Wheeler-Kingshott; M Bacon; J M Schwab; R Bosma; J Brooks; D Cadotte; T Carlstedt; O Ciccarelli; J Cohen-Adad; A Curt; N Evangelou; M G Fehlings; M Filippi; B J Kelley; S Kollias; A Mackay; C A Porro; S Smith; S M Strittmatter; P Summers; I Tracey
Journal:  Neuroimage       Date:  2013-05-14       Impact factor: 6.556

Review 5.  FDG-PET imaging in mild traumatic brain injury: a critical review.

Authors:  Kimberly R Byrnes; Colin M Wilson; Fiona Brabazon; Ramona von Leden; Jennifer S Jurgens; Terrence R Oakes; Reed G Selwyn
Journal:  Front Neuroenergetics       Date:  2014-01-09

6.  Cord compression defined by MRI is the driving factor behind the decision to operate in Degenerative Cervical Myelopathy despite poor correlation with disease severity.

Authors:  Bryn Hilton; Jennifer Tempest-Mitchell; Benjamin M Davies; Jibin Francis; Richard J Mannion; Rikin Trivedi; Ivan Timofeev; John R Crawford; Douglas Hay; Rodney J Laing; Peter J Hutchinson; Mark R N Kotter
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

7.  Prognosis Evaluation Using 18F-Alfatide II PET in a Rat Model of Spinal Cord Injury Treated With Estrogen.

Authors:  Hongpei Tan; Yongxiang Tang; Jian Li; Tingting He; Ming Zhou; Shuo Hu
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

8.  Imaging and Electrophysiology for Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 9].

Authors:  Allan R Martin; Lindsay Tetreault; Aria Nouri; Armin Curt; Patrick Freund; Vafa Rahimi-Movaghar; Jefferson R Wilson; Michael G Fehlings; Brian K Kwon; James S Harrop; Benjamin M Davies; Mark R N Kotter; James D Guest; Bizhan Aarabi; Shekar N Kurpad
Journal:  Global Spine J       Date:  2021-11-19

9.  Dynamic and Static Amplitude of Low-Frequency Fluctuation Is a Potential Biomarker for Predicting Prognosis of Degenerative Cervical Myelopathy Patients: A Preliminary Resting-State fMRI Study.

Authors:  Ningjian Fan; Bing Zhao; LiYun Liu; WeiZhen Yang; Xian Chen; ZhanBin Lu
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

10.  Clinical significance of MRI/(18)F-FDG PET fusion imaging of the spinal cord in patients with cervical compressive myelopathy.

Authors:  Kenzo Uchida; Hideaki Nakajima; Hidehiko Okazawa; Hirohiko Kimura; Takashi Kudo; Shuji Watanabe; Ai Yoshida; Hisatoshi Baba
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-02       Impact factor: 9.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.